FindTrial
Sign In

Incidence of venous thromboembolism and hemorrhage in Chinese patients after pulmonary lobectomy:mechanical prophylaxis or mechanical prophylaxis combined with pharmacological prophylaxis

Incidence of venous thromboembolism and hemorrhage in Chinese patients after pulmonary lobectomy:mechanical prophylaxis or mechanical prophylaxis combined with pharmacological prophylaxis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051073
Enrollment
Unknown
Registered
2021-09-11
Start date
2021-09-15
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

group 1:mechanical prophylaxis
group 2:mechanical prophylaxis combined with LMWH

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who were >=18 years, in good physical condition, and planned to undergo curative pulmonary lobectomy.

Exclusion criteria

Exclusion criteria: 1. Currently have peptic ulcer, or intracerebral hemorrhage or hemorrhagic transformation; 2. Severe kidney or liver disease; 3. Taking anticoagulants and/or antiplatelet drugs before surgery, such as aspirin, clopidogrel sulfate, warfarin, etc.; 4. High value of D-dimer (>10 µg/ml) within 4 weeks before surgery.

Design outcomes

Primary

MeasureTime frame
incidence of VTE and the bleeding events;—

Countries

China

Contacts

Public ContactHong Yun

The First Affiliated Hospital, College of Medicine, Zhejiang University

hong_wr@163.com+86 571 87233411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026